Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has been recognized as a Cancer Center of Excellence by the state of Florida – one of just four cancer centers in the state, and the only one in South Florida, to have earned this first-ever distinction.
In announcing the awards, Governor Rick Scott said, “These designations recognize our commitment to providing the best cancer care possible for Florida’s families and positions our state to become one of the foremost leaders in cancer care in the world.”
“I’m going to Atlanta!!!” It all poured out in a single high-pitched shriek of joy when fourth-year student Kristy Whyte opened the sealed white envelope to learn where she had been matched for her residency in emergency medicine.
A team of Miller School of Medicine researchers, collaborating with investigators at other institutions, has demonstrated that the cancer drug epothilone promotes regeneration and locomotor recovery following spinal cord injury in adult rats. The research was recently published in Science.
Miami CFAR, ISCI and Sylvester Researchers Receive Grant to Study Stem Cell Role in Kaposi’s Sarcoma
An interdisciplinary team of Miller School of Medicine researchers has received a $1.8 million grant from the National Cancer Institute to study the role of stem cells in Kaposi’s sarcoma oncogenesis and therapy.
Two important genetic studies driven by the leader of the University of Miami Miller School of Medicine’s Sylvester Comprehensive Cancer Center provide new insights into an increasingly common bone marrow disorder known as myelodysplastic syndrome (MDS).
David Zambrana, D.N.P., M.B.A., the CEO of University of Miami Hospital, received the Hispanic Leadership Award in the health care category March 20 at the annual awards luncheon held by the South Florida Hispanic Chamber of Commerce. The awards luncheon is a signature event that recognizes individuals who demonstrate excellence in a variety of fields within the Hispanic market of South Florida.